Want to join the conversation?
$LLY 2Q15 Call: LLY remains on track to return to growth in 2015, driven by excellent progress in its innovation-based strategy. LLY’s continued focus on productivity & cost controls drove strong leverage at the bottom line, while providing the capacity to fully invest in new product launches & to pursue additional promising pipeline opportunities.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)